6.97
price down icon0.85%   -0.06
after-market アフターアワーズ: 7.15 0.18 +2.58%
loading

Biocryst Pharmaceuticals Inc (BCRX) 最新ニュース

pulisher
01:43 AM

BioCryst to Present at Morgan Stanley Global Healthcare Conference - AOL.com

01:43 AM
pulisher
01:47 AM

Biotech Stocks Facing FDA Decision In December 2025 - RTTNews

01:47 AM
pulisher
Nov 20, 2025

Why BioCryst (BCRX) Might be Well Poised for a Surge - sharewise.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will BioCryst Pharmaceuticals Inc. stock return to pre crisis levelsMarket Sentiment Review & Free High Return Stock Watch Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why BioCryst Pharmaceuticals Inc. stock could benefit from AI revolutionJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

BioCryst at Jefferies Conference: Strategic Growth and Acquisitions By Investing.com - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

BCRX: ORLADEYO growth, Astria acquisition, and Nevenabart launch drive profitability and pipeline momentum - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

Why retail investors pile into BioCryst Pharmaceuticals Inc. stock2025 Market Outlook & Daily Stock Momentum Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will BioCryst Pharmaceuticals Inc. stock attract ESG investors2025 Top Decliners & Safe Swing Trade Setups - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

Can BioCryst Pharmaceuticals Inc. stock deliver consistent earnings growth2025 Valuation Update & AI Powered Market Trend Analysis - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Is BioCryst Pharmaceuticals Inc. stock ready for a breakoutGlobal Markets & Weekly Momentum Picks - newser.com

Nov 15, 2025
pulisher
Nov 13, 2025

BioCryst Pharmaceuticals Inc.’s volatility index tracking explainedPortfolio Value Report & Real-Time Volume Analysis Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition - TipRanks

Nov 13, 2025
pulisher
Nov 12, 2025

Why Analysts Say the BioCryst Story Is Changing After Astria Therapeutics Acquisition - Yahoo Finance

Nov 12, 2025
pulisher
Nov 12, 2025

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - MarketScreener

Nov 12, 2025
pulisher
Nov 11, 2025

Is BioCryst Pharmaceuticals Inc. stock bottoming out2025 Analyst Calls & Daily Technical Forecast Reports - newser.com

Nov 11, 2025
pulisher
Nov 10, 2025

Will BioCryst Pharmaceuticals Inc. stock maintain growth storyBull Run & Growth-Oriented Investment Plans - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

Trading the Move, Not the Narrative: (BCRX) Edition - news.stocktradersdaily.com

Nov 10, 2025
pulisher
Nov 07, 2025

Is BioCryst’s Surging ORLADEYO Sales and Astria Deal Reshaping the Investment Case for BCRX? - Sahm

Nov 07, 2025
pulisher
Nov 06, 2025

BioCryst Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - 富途牛牛

Nov 06, 2025
pulisher
Nov 06, 2025

Earnings Beat: BioCryst Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st

Nov 06, 2025
pulisher
Nov 06, 2025

BioCryst’s ORLADEYO shows sustained attack reduction in pediatric HAE By Investing.com - Investing.com South Africa

Nov 06, 2025
pulisher
Nov 06, 2025

BioCryst’s ORLADEYO shows sustained attack reduction in pediatric HAE - Investing.com

Nov 06, 2025
pulisher
Nov 06, 2025

BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO® (berotralstat) - GlobeNewswire

Nov 06, 2025
pulisher
Nov 06, 2025

Is BioCryst Pharmaceuticals Inc. stock ready for breakoutEarnings Risk Summary & Weekly High Potential Alerts - Fundação Cultural do Pará

Nov 06, 2025
pulisher
Nov 06, 2025

BioCryst Pharmaceuticals Shines in Q3 Earnings Call - MSN

Nov 06, 2025
pulisher
Nov 06, 2025

Can BioCryst Pharmaceuticals Inc. stock outperform in 2025 bull market2025 Breakouts & Breakdowns & Weekly High Return Forecasts - Fundação Cultural do Pará

Nov 06, 2025
pulisher
Nov 05, 2025

What technical models suggest about BioCryst Pharmaceuticals Inc.’s comebackPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

When is the best time to exit BioCryst Pharmaceuticals Inc.2025 Major Catalysts & Pattern Based Trade Signal System - newser.com

Nov 05, 2025
$34.71
price up icon 3.24%
$22.25
price up icon 4.76%
drug_manufacturers_specialty_generic RDY
$13.91
price up icon 0.07%
$10.46
price up icon 2.65%
$141.83
price up icon 2.05%
$474.82
price up icon 0.02%
大文字化:     |  ボリューム (24 時間):